BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38414825)

  • 41. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.
    Remold-O'Donnell E; Cooley J; Shcherbina A; Hagemann TL; Kwan SP; Kenney DM; Rosen FS
    J Immunol; 1997 May; 158(9):4021-5. PubMed ID: 9126958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus.
    Kolluri R; Shehabeldin A; Peacocke M; Lamhonwah AM; Teichert-Kuliszewska K; Weissman SM; Siminovitch KA
    Hum Mol Genet; 1995 Jul; 4(7):1119-26. PubMed ID: 8528198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
    Shcherbina A; Rosen FS; Remold-O'Donnell E
    J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response.
    Westerberg L; Larsson M; Hardy SJ; Fernández C; Thrasher AJ; Severinson E
    Blood; 2005 Feb; 105(3):1144-52. PubMed ID: 15383456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene.
    Hagemann TL; Kwan SP
    Biochem Biophys Res Commun; 1999 Mar; 256(1):104-9. PubMed ID: 10066431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome.
    Sarkar K; Han SS; Wen KK; Ochs HD; Dupré L; Seidman MM; Vyas YM
    J Allergy Clin Immunol; 2018 Jul; 142(1):219-234. PubMed ID: 29248492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.
    Marangoni F; Bosticardo M; Charrier S; Draghici E; Locci M; Scaramuzza S; Panaroni C; Ponzoni M; Sanvito F; Doglioni C; Liabeuf M; Gjata B; Montus M; Siminovitch K; Aiuti A; Naldini L; Dupré L; Roncarolo MG; Galy A; Villa A
    Mol Ther; 2009 Jun; 17(6):1073-82. PubMed ID: 19259069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice.
    Recher M; Burns SO; de la Fuente MA; Volpi S; Dahlberg C; Walter JE; Moffitt K; Mathew D; Honke N; Lang PA; Patrizi L; Falet H; Keszei M; Mizui M; Csizmadia E; Candotti F; Nadeau K; Bouma G; Delmonte OM; Frugoni F; Fomin AB; Buchbinder D; Lundequist EM; Massaad MJ; Tsokos GC; Hartwig J; Manis J; Terhorst C; Geha RS; Snapper S; Lang KS; Malley R; Westerberg L; Thrasher AJ; Notarangelo LD
    Blood; 2012 Mar; 119(12):2819-28. PubMed ID: 22302739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages.
    Tsuboi S
    J Immunol; 2007 Mar; 178(5):2987-95. PubMed ID: 17312144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
    Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
    J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.
    Sarkar K; Sadhukhan S; Han SS; Vyas YM
    Blood; 2014 Nov; 124(23):3409-19. PubMed ID: 25253772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein.
    Wu Y; Spencer SD; Lasky LA
    J Biol Chem; 1998 Mar; 273(10):5765-70. PubMed ID: 9488710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
    Imai K; Nonoyama S; Ochs HD
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
    Candotti F; Facchetti F; Blanzuoli L; Stewart DM; Nelson DL; Blaese RM
    Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of WASp in T cells and B cells.
    Sun X; Wei Y; Lee PP; Ren B; Liu C
    Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
    Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
    Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.
    Scaramuzza S; Biasco L; Ripamonti A; Castiello MC; Loperfido M; Draghici E; Hernandez RJ; Benedicenti F; Radrizzani M; Salomoni M; Ranzani M; Bartholomae CC; Vicenzi E; Finocchi A; Bredius R; Bosticardo M; Schmidt M; von Kalle C; Montini E; Biffi A; Roncarolo MG; Naldini L; Villa A; Aiuti A
    Mol Ther; 2013 Jan; 21(1):175-84. PubMed ID: 22371846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
    Sasahara Y; Tsuchiya S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
    Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
    J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.